These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10739116)

  • 21. Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.
    Boer R; Ulrich WR; Haas S; Borchers C; Gekeler V; Boss H; Przybylski M; Schödl A
    Eur J Pharmacol; 1996 Jan; 295(2-3):253-60. PubMed ID: 8720592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein.
    Martin C; Higgins CF; Callaghan R
    Biochemistry; 2001 Dec; 40(51):15733-42. PubMed ID: 11747450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
    Sharom FJ; Yu X; DiDiodato G; Chu JW
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335).
    Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI
    Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.
    Martin C; Berridge G; Mistry P; Higgins C; Charlton P; Callaghan R
    Br J Pharmacol; 1999 Sep; 128(2):403-11. PubMed ID: 10510451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
    Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA
    J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin.
    Pouliot JF; L'Heureux F; Liu Z; Prichard RK; Georges E
    Biochem Pharmacol; 1997 Jan; 53(1):17-25. PubMed ID: 8960059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
    Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
    J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical mechanism of modulation of human P-glycoprotein by stemofoline.
    Chanmahasathien W; Ohnuma S; Ambudkar SV; Limtrakul P
    Planta Med; 2011 Dec; 77(18):1990-5. PubMed ID: 21786221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
    Sachs CW; Safa AR; Harrison SD; Fine RL
    J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance.
    Muñoz-Martínez F; Lu P; Cortés-Selva F; Pérez-Victoria JM; Jiménez IA; Ravelo AG; Sharom FJ; Gamarro F; Castanys S
    Cancer Res; 2004 Oct; 64(19):7130-8. PubMed ID: 15466210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
    Doige CA; Sharom FJ
    Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.
    Traunecker HC; Stevens MC; Kerr DJ; Ferry DR
    Br J Cancer; 1999 Nov; 81(6):942-51. PubMed ID: 10576649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
    Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
    Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.